Mammalian cells display remarkable capacities for migration, invasion, and morphological plasticity. These attributes make possible numerous biological processes of central interest in the understanding of development, homeostasis and disease, including metastasis. Metastasis is a major therapeutic challenge-few treatments exist that effectively treat metastatic disease, and metastases are responsible for >90% of cancer deaths. Metastatic cancer cells are capable of migration and invasion through extracellular matrix (ECM) barriers present in tissues, intravasation into lymphatics or bloodstream, extravasation, and dissemination and growth at a new site and these processes depend upon dynamic modulation of the cytoskeleton. A thorough understanding of the contribution of proteins regulating the actin cytoskeleton during cell migration and invasion is essential for progress in diagnosis and therapy of metastasis.
effecters such as mDia2 promote contraction of cortical actin and are associated with dynamic membrane blebbing. Bleb extrusion allows amoeboid cells to squeeze through gaps and adapt the cell body to preexisting spaces in the ECM, or exert sufficient force to deform the ECM fibers [8] [9] [10] .
The canonical mammalian Diaphanous (mDia)-related Formin-2 regulates the cortical actin cytoskeleton through association with Diaphanous-interacting protein (DIP). Upon interacting with mDia2, DIP inhibits mDia2's ability to nucleate, processively elongate and bundle non-branched Factin. Direct interaction between the Formin homology-2 (FH2) domain and the leucine-rich DIP Cterminus (LRR)) disrupts the cortical actin cytoskeleton, triggering non-apoptotic plasma membrane blebbing on two-dimensional (2D) matrices. Membrane blebbing is a physiological process engaging elements of the contractile machinery and functions in ACM. Here we demonstrate a tightly regulated complex between mDia2 and DIP that deregulates mDia2-dependent F-actin dynamics in vitro and in vivo and induces membrane blebbing. Confocal microscopy reveals that both DIP and mDia2 are dynamically localized to blebs in constitutively blebbing cancer cells in both 2D and 3D, suggesting a critical role in cortical contractility fundamental to the amoeboid phenotype. Conversely, depleting DIP inhibits ACM and promotes elongated, filopodia-rich morphology in breast cancer cells predisposed to this type of 3D migration. We propose that DIP and mDia2 comprise a precise regulatory mechanism controlling cortical actin assembly and are required for driving cortical contractility and the amoeboid-type of cancer cell invasion. Understanding the molecular basis of amoeboid cell movement will lend novel insight into mechanisms controlling and contributing to cancer cell migration, invasion, and metastasis and may provide a critically needed alternate therapeutic for metastatic disease. 
